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Backround: A fall in FEV1 of >10% following bronchoprovocation (eucapnic voluntary hyperventilation
(EVH) or exercise) is regarded as the gold standard criterion for diagnosing exercise induced asthma (EIA)
in athletes. Previous studies have suggested that mid-expiratory flow (FEF50) might be used to supplement
FEV1 to improve the sensitivity and specificity of the diagnosis. A study was undertaken to investigate the
response of FEF50 following EVH or exercise challenges in elite athletes as an adjunct to FEV1.
Methods: Sixty six male (36 asthmatic, 30 non-asthmatic) and 50 female (24 asthmatic, 26 non-asthmatic)
elite athletes volunteered for the study. Maximal voluntary flow-volume loops were measured before and
3, 5, 10, and 15 minutes after stopping EVH or exercise. A fall in FEV1 of >10% and a fall in FEF50 of
>26% were used as the cut off criteria for identification of EIA.
Results: There was a strong correlation between DFEV1 and DFEF50 following bronchoprovocation
(r = 0.94, p = 0.000). Sixty athletes had a fall in FEV1 of >10% leading to the diagnosis of EIA. Using the
FEF50 criterion alone led to 21 (35%) of these asthmatic athletes receiving a false negative diagnosis. The
lowest fall in FEF50 in an athlete with a>10% fall in FEV1 was 14.3%. Reducing the FEF50 criteria to>14%
led to 13 athletes receiving a false positive diagnosis. Only one athlete had a fall in FEF50 of >26% in the
absence of a fall in FEV1 of >10% (DFEV1 = 8.9%).
Conclusion: The inclusion of FEF50 in the diagnosis of EIA in elite athletes reduces the sensitivity and does
not enhance the sensitivity or specificity of the diagnosis. The use of FEF50 alone is insufficiently sensitive to
diagnose EIA reliably in elite athletes.
E
xercise induced asthma (EIA) occurs in approximately
90% of chronic asthmatics1 and has previously been
reported to occur in 7–50% of athletic individuals.2–6
Asthmatic elite athletes currently require evidence of asthma
to obtain a therapeutic use exemption certificate which
enables them to use therapeutic doses of inhaled b2 agonists
in and out of competition.7 EIA has previously been
diagnosed by a number of challenge methods including
exercise,8 9 eucapnic voluntary hyperventilation (EVH),10 11
methacholine,12 13 histamine,14 saline,15 and mannitol.16 17
The International Olympic Committee’s Medical
Commission (IOC-MC) considers positive tests from exercise,
EVH, saline, histamine, and methacholine challenges as
evidence of EIA. Methacholine and histamine, however, have
been shown to be less specific than exercise for EIA
diagnosis.16 18 19 Exercise and EVH challenges are regarded
as the most specific methods of diagnosing EIA in elite
athletes.11
In all EIA tests recognised by the IOC-MC, forced
expiratory volume in 1 second (FEV1) is the parameter by
which changes in maximal expiratory function are assessed,
but no ‘‘gold standard’’ methodology exists for athletes or
non-athletes.20 Previous studies that have used FEV1 to
diagnose EIA have suggested using falls in FEV1 ranging
from 7% to 20% as cut off criteria.21–23 The work carried out by
Helenius et al23 suggests that a fall of 10% in FEV1 following
an exercise test is not sensitive enough to diagnose EIA in
elite athletes. Despite the absence of a ‘‘gold standard’’
methodology for diagnosing EIA in athletes, the IOC-MC has
ruled that an exercise or EVH challenge is positive for EIA
when the FEV1 falls >10% from the baseline measurement.
It is possible that the addition of other measurements of
expiratory lung function may provide greater sensitivity in
the diagnosis of EIA. For example, forced expiratory flow
between 25–75% of vital capacity (FEF25–75) has been used in
conjunction with FEV1 to aid the diagnosis of EIA in
children24 25 and athletes.8 26 Implicitly, FEV1 measures
expiratory flow at high and mid lung volumes, whereas
FEF25–75 and forced expiratory flow at 50% of vital capacity
(FEF50) are markers of expiratory flow through middle lung
volumes. It has been suggested that FEF25–75 and FEF50 are
more sensitive to airway obstruction in the small airways
than FEV1.
27 28 Custovic et al24 noted that cut off points for EIA
in children (defined as the normal group mean value 22 SD)
occurred with a fall in FEV1 of .10% and a fall in FEF25–75 of
.26%. In this study, the combined application of FEV1 and
FEF25–75 criteria enabled detection of all subjects with EIA.
Furthermore, using both FEV1 and FEF25–75 criteria, none of
the subjects with allergic rhinitis or dermatitis presented with
EIA. The fall in FEV1 after exercise in children with allergic
rhinitis was within the normal range ((2SD), but with a
significantly lower mean value than control subjects. The
study by Custovic et al24 therefore provides promising
evidence to support the addition of mid expiratory flow rates
to FEV1 in the diagnosis of EIA in children that might also be
applied to elite athletes. FEF50 and FEF25–50 measurements
are highly correlated and the ratio of the two is reasonably
constant. Based on this finding, Bar-Yishay et al29 suggested
that reporting both measurements is unnecessary, and they
suggested that FEF50 should be the preferred measure. This
preference was based on the argument that FEF50 is easily
and directly determined while FEF25–50 is a calculated
Abbreviations: EIA, exercise induced asthma; EVH, eucapnic voluntary
hyperventilation; FEF50, forced expiratory flow at 50% of vital capacity;
FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity
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parameter that is affected by the spirometer manufacturer’s
choice of algorithm.
The purpose of the present study was to examine the role
of FEF50 as an adjunct to FEV1 in the diagnosis of EIA in elite
athletes following a bronchoprovocation challenge.
METHODS
Following ethical approval from Harrow local research ethics
committee, 66 male elite summer and winter athletes of
mean (SD) age 25.1 (4.9) years, height 180.7 (7.8) cm, body
mass 77.3 (12.5) kg and 50 female elite athletes of mean
(SD) age 24.3 (5.4) years, height 168.2 (7.9) cm, and body
mass 62.6 (9.9) kg who held either a Gold or Silver British
Olympic Association passport (indicating current or potential
Olympic competitive standard) provided written informed
consent and volunteered for the study. Of the athletes who
participated in this study, 83 had a previous diagnosis of EIA
and where using asthma medication. The other 33 athletes
had reported symptoms of EIA to a sports physician who had
referred them to be tested for EIA. The testing took place at
the Olympic Medical Institute, Harrow between June 2003
and June 2004. Athletes were tested at least 2 weeks after a
respiratory infection and at least 12 hours following a
training session.
Each athlete completed either an exercise or EVH
challenge. Exercise challenges involved exercising at an
intensity of .85% of maximal heart rate for 6–10 minutes
in a sport-specific environment.30 EVH challenges consisted
of hyperventilating for 6 minutes at a rate of 85% maximal
voluntary ventilation (30 6baseline FEV1). The gas inspired
during the EVH challenge was a medical gas containing 21%
O2, 5% CO2 and 74% N2.
31 For both exercise and EVH
challenges, maximal flow-volume loops were measured
before and at 3, 5, 10 and 15 minutes after stopping exercise
or EVH using a digital spirometer (MicroLab ML3500, Micro
Medical Ltd, Rochester, UK) which met ATS guidelines. The
lowest values of FEV1 and FEF50 following either exercise or
EVH were recorded and the change was calculated (D). A
DFEV1 of >210% and DFEF50 of >226% were considered
cut off criteria for EIA diagnosis.24
RESULTS
There was a strong positive correlation between DFEV1 and
DFEF50 following bronchoprovocation (r = 0.94, p = 0.000).
Sixty athletes (52%) had a DFEV1 fall of >10% leading to the
diagnosis of EIA (fig 1). Using the FEF50 criteria alone led to
21 (35%) asthmatic athletes receiving a false negative
diagnosis; thus, 39 athletes met both FEV1 and FEF50 criteria.
The lowest fall in DFEF50 in an athlete with a >10% fall in
FEV1 was 14.3%. Reducing the FEF50 criterion to a >14% fall
included 13 athletes whose DFEV1 was not >10% (mean
DFEV1 = 5.7, range 28.9 to 21.5). Only one athlete had a
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Figure 1 Delta FEV1 versus delta FEF50.
Table 1 Mean (SD) changes in FEF50 and FVC following bronchoprovocation challenge
FEF50 (l/s) FVC (l)
Before After Before After
Asthmatic 3.86 (0.92) 2.39 (0.84)** 4.99 (1.00) 4.45 (1.16)**
Non-asthmatic 4.79 (1.37) 4.43 (1.31) 4.81 (1.03) 4.65 (1.04)
Asthmatic athlete defined as having a >10% fall in FEV1 following bronchoprovocation.
**Significantly different (p,0.05) from pre-test value.
Table 2 True and false positive and negative
diagnoses based on FEF50 cut off value of 26%
True positive 39
True negative 55
Total true 94
False negative 21
False positive 1
Total false 22
Total with EIA 60
Total without EIA 56
Total 116
True positive =DFEV1 of >10% and a fall in FEF50 of >26%.
True negative =DFEV1 of >10% and did not have a fall in
FEF50 of >26%.
False positive =DFEV1 of (10% and a fall in FEF50 of
>26%.
False negative =DFEV1 of >10% and a fall in FEF50 of
(26%.
Table 3 True and false positive and negative
diagnoses based on FEF50 cut off value of 14%
True positive 51
True negative 43
Total true 94
False negative 9
False positive 13
Total false 22
Total with EIA 60
Total without EIA 56
Total 116
True positive =DFEV1 of >10% and a fall in FEF50 of >14%.
True negative =DFEV1 of >10% and did not have a fall in
FEF50 of >14%.
False positive =DFEV1 of (10% and a fall in FEF50 of
>14%.
False negative =DFEV1 of >10% and a fall in FEF50 of
(14%.
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>26% fall in FEF50 in the absence of a >10% in FEV1
(DFEV1 = 8.9%).
Of the 83 athletes with a previous diagnosis of EIA, 33
failed to develop EIA (DFEV1 ,10%) following bronchopro-
vocation challenge. Of the 33 athletes who had been referred
for testing but had no previous diagnosis of EIA, 10 athletes
presented with EIA following bronchoprovocation.
The values for FEF50 and forced vital capacity (FVC) before
and after bronchoprovocation challenge are shown in table 1.
FEF50 (p = 0.000) and FVC (p = 0.000) were significantly
lower after bronchoprovocation in the asthmatic athletes.
There was no significant change in FEF50 or FVC before and
after bronchoprovocation challenge in athletes who did not
have a fall in FEV1 of >10%.
The specificity, sensitivity, predictive value of positive test
and efficiency of FEF50 cut off criteria of 26% and 14% are
shown in tables 2, 3 and 4, respectively.
DISCUSSION
This study shows that the addition of FEF50 reduces the
sensitivity of EIA diagnosis following exercise or EVH
challenge. Of the 60 athletes who were diagnosed with EIA
using IOC-MC criteria of a >10% fall in FEV1, 21 (35%)
would have received a false negative diagnosis using a
combination of FEV1 and FEF50 falls. Furthermore, only one
athlete exceeded the criterion for FEF50 but not for FEV1. Our
study therefore suggests that FEF50 does not improve the
diagnosis of EIA in elite athletes using the IOC-MC criteria.
In previous studies, measurements of FEF25–75 have been
used to supplement FEV1 in the diagnosis of EIA in
children24 25 and athletes.8 26 The studies conducted on
children have supported the addition of FEF25–75 measure-
ments to improve the diagnosis of EIA. It has been suggested
that FEF25–75 is a more sensitive measure of obstruction in
the small airways than FEV1.
32 Thus, EIA may be a disease
that consistently affects the expiratory flow through the
small airways. Fonseca-Guedes et al25 noted that only 60% of
children with ‘‘intermittent’’ EIA met the criteria for both
FEV1 and FEF25–75 compared with 94.4% of children with
‘‘severe persistent’’ EIA. They suggested that FEF25–75 is more
likely to fall significantly than FEV1 in children with mild
EIA. Our data do not agree with this finding and suggest that
FEV1 is more likely to fall significantly in athletes with mild
asthma. Indeed, only one athlete had a significant fall in
FEF50 (>26%) in the absence of a significant fall in FEV1,
while 21 athletes had a significant fall in FEV1 (>10%) in the
absence of a significant fall in FEF50. Only 39 athletes met
both criteria for FEF50 and FEV1, which would have resulted
in 21 (35%) athletes (who met FEV1 criteria) receiving a false
negative diagnosis for EIA. The reduced sensitivity found
following the inclusion of the FEF50 measurement suggests
that, in elite athletes with mild EIA, expiratory airflow is just
as likely to be restricted in the larger airways as in the smaller
airways. It is therefore appropriate to assess expiratory flow
using an index of function for both the larger and smaller
airways of the lung—that is, FEV1.
A number of studies have examined the diagnosis of EIA in
athletes but they have not specifically used mid-expiratory
flow rates as a criterion for making the diagnosis. Rundell et
al8 suggested that a fall in FEF25–75 of 14% is significant in the
diagnosis of EIA in winter athletes. This lower limit was
calculated by taking the mean post exercise change from
baseline spirometry and subtracting 2 standard deviations.
Lowering the FEF50 cut off value in our data to >14%
resulted in an increase in the sensitivity but a decrease in the
specificity from 98% to 77%. Using a 14% cut off value, 13
athletes would have been diagnosed with EIA who did not
meet the IOC-MC criterion of a 10% fall in FEV1 from
baseline values.
A further problem associated with the use of FEF50 as a
criterion measurement is that its reliability is dependent
upon the constancy of FVC. Our results show that the mean
fall in FEF50 following bronchoconstriction was accompanied
by a mean fall in FVC in athletes with EIA. The fall in FEF50
seen in some of athletes following a bronchoprovocation test
may therefore be partially attributable to a reduction in FVC.
The reduction in FVC in asthmatic athletes may be due to the
prolongation and discomfort associated with exhaling to
residual volume during bronchoconstriction. Despite stan-
dard controls, this may cause the athlete to stop exhaling
before reaching residual volume. This shortcoming further
undermines the potential value of FEF50 for diagnosing EIA.
In conclusion, the addition of FEF50 to FEV1 reduces the
sensitivity of a diagnosis of EIA in elite athletes. Our data
suggest that a more global measure of maximal expiratory
airflow (FEV1) provides the most sensitive and specific
diagnosis of EIA, especially when the severity of the disease
is thought to be mild. This would suggest that EIA is a disease
that is associated with expiratory flow limitation in the larger
and smaller airways of elite athletes. However, methodolo-
gical issues associated with assessment of FEF50 (reliance
upon FVC) mean that this interpretation should be viewed
cautiously. The authors suggest that future studies should
investigate the efficacy of the IOC-MC criterion of a 10% fall
in FEV1 to define a more statistically justified cut off point for
the diagnosis of EIA in elite athletes.
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